1800 Successful Transplants

Modern medicine considers stem cell transplant to be a planned treatment method that turns one of the most sinister and rare diseases into controllable conditions.

Bone marrow transplants treat onco-hematological diseases such as leukaemia, lymphoma, myeloma, spinal cord abnormalities (myelodysplasias), autoimmune diseases as well as solid testicular tumours, ovarian cancer, Ewing's sarcoma, etc. The treatment of onco-hematological diseases requires high professionalism, innovative solutions and specific state-of-the-art equipment

The Hematologic Oncology and Bone Marrow Transplant Program was launched in 2010 and over the years, it has become one of the most successful specialties of the Anadolu Medical Center. By September 2018, over 1,800 successful transplants had successfully been carried out at the Specialized Centre. Thus, it is among the top five European clinics for bone marrow transplants.

This exceptional success is due to a number of important factors such as the outstanding qualification and expertise of the team, their multi-disciplinary approach, the special infrastructure and design of the centre that allows for optimal atmosphere for patients throughout the treatment process with minimal risk of infections.

The Bone Marrow Transplant Centre is a hospital unit entirely isolated from the rest of the Anadolu Medical Centre. The specialized centre includes state-of-the-art equipment in the clinic, while inpatient  rooms are  equipped to suit patients‘ comfort and reduce the risk of infections

The Centre’s team consists of 6 physicians, 4 biologists, 35 nurses and 2 process management specialists. Professor Dr. Zafer Gülbash, an internationally renowned specialist in hematologic oncology, manages the centre. Specialists examine patient's molecular risk profile and elaborate an individual treatment plan. The joint work with internal medicine specialists ensures the best treatment for patients.

Anadolu Medical Centre strictly observes the international standards and treatment approaches, audited annually by Johns Hopkins Medicine, USA.

Commenting disabled.

Related Articles

  • The Lethal Sarcoma
    The Lethal Sarcoma
    Sarcoma is a rare occurrence, approximately 10% of all malignant tumors. Statistics, however show, that it is featured by ...
  • Cyberknife M6
    Cyberknife M6
    Why is the new generation Cyberknife M6 one of the most efficient devices in radiation oncology? Cyberknife M6 uses extrem...